Fusion Pharmaceuticals Inc.
FUSN · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$34 | -$28 | -$17 | -$25 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | -$0 | $3 | -$1 | -$1 |
| Stock-Based Comp. | $5 | $3 | $3 | $3 |
| Change in WC | $2 | $3 | -$4 | $3 |
| Other Non-Cash | $4 | $2 | $0 | -$1 |
| Operating Cash Flow | -$27 | -$17 | -$19 | -$20 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$1 | -$0 | -$1 |
| Net Acquisitions | $0 | -$49 | -$14 | $26 |
| Inv. Purchases | -$119 | -$56 | -$39 | -$70 |
| Inv. Sales/Matur. | $50 | $53 | $53 | $44 |
| Other Inv. Act. | -$69 | $49 | $14 | -$26 |
| Investing Cash Flow | -$70 | -$5 | $13 | -$26 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $49 | $56 | $0 | $24 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $64 | $58 | $0 | $24 |
| Financing Cash Flow | $64 | $56 | $0 | $24 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$34 | $35 | -$5 | -$22 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $62 | $27 | $33 | $55 |
| End Cash | $28 | $62 | $28 | $33 |
| Free Cash Flow | -$29 | -$18 | -$19 | -$20 |